trending Market Intelligence /marketintelligence/en/news-insights/trending/ifgEzqgGTja5wA7BKBrA8w2 content esgSubNav
In This List

Heron Therapeutics CFO resigns

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Heron Therapeutics CFO resigns

Brian Drazba resigned as Heron Therapeutics Inc.'s CFO and vice president of finance, effective March 31.

The company accepted Drazba's resignation Sept. 30, 2016.

In connection with Drazba's departure, CEO Barry Quart became principal financial officer and principal accounting officer, effective April 1.